Franklin India Flexi Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Franklin India Flexi Cap Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Franklin India Flexi Cap Fund - Direct (G)

-2.04%

stock2

Nippon India Pharma Fund - Direct (G)

7.4%

Loading chart...

About Fund

Citibank N.A. Deutsche Bank

Franklin Templeton Asset Management (India) Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

19274.14

1.76

1789.5072

January 1, 2013

0

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

14.04 %

13.05 %

-2.04 %

14.01 %

19.35 %

7.4 %

Anand Radhakrishnan

B.Tech.,PGDM (IIM),CFA CFA, PGDM (IIM) B.Tech.

Prior assignments: . 2004-2006, Fund Manager for the Portfolio Management Services of the AMC. . 1996-2004, Fund Manager - Sundaram Asset Management s Ltd. . 1994-1996, Deputy Manager, Portfolio Manager of Asian Convertible and Income Fund - SBI Funds Managements Ltd.

Rajasa Kakulavarapu

B.Tech. (ECE) from NIT, Jaipur and MBA from Indian Institute of Management, Ahmedabad

She is responsible for equity research support and fund management. (Based at Chennai) Prior Assignments:  Franklin Templeton Asset Management (India) Pvt. Ltd. (Since 2016 till date): AVP/Senior Research Analyst.  Jefferies India Pvt. Ltd. (June 2011 to March 2016)  Credit Suisse Securities (India) Pvt. Ltd. (May 2008 to June 2011)

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right